These findings indicate that such a physical intervention constitutes an effective strategy for mitigating low-grade chronic inflammation commonly associated with metabolic diseases such as obesity and type 2 diabetes through the downregulation of the NLRP3 inflammasome. The gene discussed is NLRP3; the disease is obesity due to melanocortin 4 receptor deficiency.